Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Autolus Therapeutics Announces Changes to its Board of Directors
-
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
-
Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certification for Nucleus commercial manufacturing site
-
Autolus Therapeutics announces publication in Blood Cancer Journal
-
Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024
-
Autolus Therapeutics announces publication in Nature Communications
-
Autolus Announces Pricing of Underwritten Offering
-
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
-
Autolus Therapeutics announces publication in ACS Chemical Biology
-
Autolus Therapeutics announces acceptance of BLA for obe-cel as a potential treatment for relapsed/refractory adult ALL